Form 8-K - Current report:
SEC Accession No. 0001628280-22-025522
Filing Date
2022-09-27
Accepted
2022-09-27 08:08:53
Documents
16
Period of Report
2022-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zlab-20220923.htm   iXBRL 8-K 42431
2 EX-99.1 zlab-projectdawnex991.htm EX-99.1 32571
7 image1a.jpg GRAPHIC 7063
8 imagea.jpg GRAPHIC 9385
  Complete submission text file 0001628280-22-025522.txt   288445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20220923.xsd EX-101.SCH 2268
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20220923_def.xml EX-101.DEF 15931
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20220923_lab.xml EX-101.LAB 30647
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20220923_pre.xml EX-101.PRE 16624
10 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20220923_htm.xml XML 13971
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 221267381
SIC: 2834 Pharmaceutical Preparations